Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

Roy N, Bommi PV, Bhat UG, Bhattacharjee S, Elangovan I, Li J, Patra KC, Kopanja D, Blunier A, Benya R, Bagchi S, Raychaudhuri P.

Cancer Res. 2013 Jun 15;73(12):3771-82. doi: 10.1158/0008-5472.CAN-12-4069. Epub 2013 Apr 22.

2.

NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.

Jin Y, Li F, Zheng C, Wang Y, Fang Z, Guo C, Wang X, Liu H, Deng L, Li C, Wang H, Chen H, Feng Y, Ji H.

Int J Cancer. 2014 May 15;134(10):2294-304. doi: 10.1002/ijc.28568. Epub 2013 Nov 15.

3.

HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.

Belton A, Gabrovsky A, Bae YK, Reeves R, Iacobuzio-Donahue C, Huso DL, Resar LM.

PLoS One. 2012;7(1):e30034. doi: 10.1371/journal.pone.0030034. Epub 2012 Jan 20.

4.

L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.

Gavert N, Vivanti A, Hazin J, Brabletz T, Ben-Ze'ev A.

Mol Cancer Res. 2011 Jan;9(1):14-24. doi: 10.1158/1541-7786.MCR-10-0406. Epub 2010 Dec 1.

5.

HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.

Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z, You T.

Cancer Lett. 2014 Dec 1;355(1):130-40. doi: 10.1016/j.canlet.2014.09.007. Epub 2014 Sep 11.

PMID:
25218351
6.

Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.

Qi L, Sun B, Liu Z, Cheng R, Li Y, Zhao X.

J Exp Clin Cancer Res. 2014 Dec 11;33:107. doi: 10.1186/s13046-014-0107-4.

7.

Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.

Wang H, Zhang H, Tang L, Chen H, Wu C, Zhao M, Yang Y, Chen X, Liu G.

Toxicology. 2013 Jan 7;303:139-46. doi: 10.1016/j.tox.2012.09.017. Epub 2012 Nov 9.

PMID:
23146760
8.

Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.

Cui B, Zhang S, Chen L, Yu J, Widhopf GF 2nd, Fecteau JF, Rassenti LZ, Kipps TJ.

Cancer Res. 2013 Jun 15;73(12):3649-60. doi: 10.1158/0008-5472.CAN-12-3832.

9.

Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.

Park MK, You HJ, Lee HJ, Kang JH, Oh SH, Kim SY, Lee CH.

Eur J Cancer. 2013 May;49(7):1692-705. doi: 10.1016/j.ejca.2012.11.036. Epub 2013 Jan 2.

PMID:
23290789
10.

Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers.

Jang TJ, Jeon KH, Jung KH.

Yonsei Med J. 2009 Dec 31;50(6):818-24. doi: 10.3349/ymj.2009.50.6.818. Epub 2009 Dec 18.

11.

Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.

Rosanò L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, Natali PG, Bagnato A.

Cancer Res. 2005 Dec 15;65(24):11649-57.

12.

Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.

Zhang H, Meng F, Wu S, Kreike B, Sethi S, Chen W, Miller FR, Wu G.

Cancer Res. 2011 Jul 15;71(14):4846-56. doi: 10.1158/0008-5472.CAN-11-0414. Epub 2011 Jul 12.

13.

Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.

Lu MH, Huang CC, Pan MR, Chen HH, Hung WC.

Clin Cancer Res. 2012 Dec 1;18(23):6416-25. doi: 10.1158/1078-0432.CCR-12-0832. Epub 2012 Oct 8.

14.

Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.

Guha M, Srinivasan S, Ruthel G, Kashina AK, Carstens RP, Mendoza A, Khanna C, Van Winkle T, Avadhani NG.

Oncogene. 2014 Nov 6;33(45):5238-50. doi: 10.1038/onc.2013.467. Epub 2013 Nov 4.

PMID:
24186204
15.

Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression.

Qi L, Sun B, Liu Z, Li H, Gao J, Leng X.

Cancer Sci. 2012 Apr;103(4):828-35. doi: 10.1111/j.1349-7006.2012.02222.x. Epub 2012 Feb 23.

16.

Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.

Todosi AM, Gavrilescu MM, Aniţei GM, Filip B, Scripcariu V.

Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1106-11. Review.

PMID:
23700897
17.

Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.

Cai WK, Hu J, Li T, Meng JR, Ma X, Yin SJ, Zhao CH, He GH, Xu GL.

Eur J Cancer. 2014 Apr;50(6):1195-206. doi: 10.1016/j.ejca.2013.12.025. Epub 2014 Jan 18.

PMID:
24447834
18.

MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.

Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.

Oncogene. 2013 Dec 12;32(50):5614-24. doi: 10.1038/onc.2013.322. Epub 2013 Aug 19.

19.

Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice.

Wang Q, Zhu J, Zhang Y, Sun Z, Guo X, Wang X, Lee E, Bakthavatchalu V, Yang Q, Yang HS.

Eur J Cancer. 2013 May;49(7):1761-70. doi: 10.1016/j.ejca.2012.12.014. Epub 2013 Jan 10.

20.

Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.

Zhan J, Niu M, Wang P, Zhu X, Li S, Song J, He H, Wang Y, Xue L, Fang W, Zhang H.

Br J Cancer. 2014 Aug 26;111(5):883-93. doi: 10.1038/bjc.2014.387. Epub 2014 Jul 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk